# Adaptogens

Rating: Promising — Some human trials, or consistent animal work with a clear mechanism
Type: Compound
Updated: 2026-08-06
Canonical: https://heretic.bio/articles/adaptogen-research.html

> Adaptogens are a class of plant compounds, defined in Soviet-era research, claimed to increase the body's nonspecific resistance to stress via HPA-axis and stress-protein modulation. The strongest modern evidence is randomized-trial support for rhodiola in stress-related fatigue and ashwagandha for cortisol and anxiety. Other adaptogens rest on thinner or Soviet-era data, and extract standardization and trial heterogeneity are the main caveats.

> **Core thesis:** Adaptogens — a concept born in Soviet military research — are substances that increase the organism's nonspecific resistance to stress. First defined by Nikolai Lazarev in 1947 and systematized by Israel Brekhman, adaptogens modulate the hypothalamic-pituitary-adrenal (HPA) axis, reduce fatigue, and improve performance under stress without the side effects of stimulants. The concept has since been refined with modern mechanistic research and human RCTs, though extract standardization and trial quality remain heterogeneous.

* * *

## History of Adaptogen Science

### The Soviet Origins

Year | Event  
---|---  
1947 | Nikolai Lazarev coins "adaptogen" — a substance that increases "the state of nonspecific resistance" to stress  
1950s-60s | Israel Brekhman at the Far East Science Center systematically studies _Panax ginseng_ , _Eleutherococcus senticosus_ , _Rhaponticum carthamoides_ , and _Schisandra chinensis_  
1960s-80s | Soviet military, Olympic athletes, cosmonauts, deep-sea divers, and industrial workers use adaptogens for performance under extreme conditions  
1990s | Post-Soviet disruption; research largely abandoned; Western interest grows slowly  
  
### Brekhman's Original Criteria for Adaptogens

  1. Produces a **nonspecific increase in resistance** to multiple stressors (physical, chemical, biological)
  2. Has a **normalizing effect** regardless of the direction of pathological deviation (bidirectional regulation)
  3. Is **innocuous** and does not disturb normal physiological functions at therapeutic doses



These three criteria distinguish adaptogens from stimulants (which increase function but also disturb homeostasis) and sedatives (which suppress function).

### Why This Research Was Systematically Ignored in the West

  * Published primarily in Russian-language journals, conference proceedings, and institutional monographs
  * Cold War ideological barriers made Soviet publications suspect in Western biomedicine
  * **No patent potential** — natural botanical substances cannot be patented → no pharmaceutical industry investment
  * Conflict with Western pharmacology's stimulant/depressant binary model
  * Soviet pragmatic trial designs did not map onto Western RCT expectations
  * After Soviet collapse (1991), institutional continuity was broken; many researchers emigrated



* * *

## Mechanism of Action

### The Stress-System Modulation Model

Adaptogens do not act through a single pathway. The convergent mechanism is **stress-system normalization** :

  1. **HPA axis regulation** — Modulate cortisol rhythm: reduce excessive cortisol in stressed states, support cortisol output in depleted states. This bidirectional effect is the hallmark of adaptogen activity.
  2. **Neurotransmitter modulation** — Influence serotonin, dopamine, norepinephrine, and GABA systems, particularly under stress-induced dysregulation
  3. **Molecular chaperone induction** — Upregulate HSP70 and HSP90 (heat shock proteins), which protect cells from stress-induced protein misfolding and aggregation
  4. **Anti-inflammatory** — NF-κB modulation, reduced IL-6, TNF-α, and other pro-inflammatory cytokines
  5. **Mitochondrial support** — Improved ATP production efficiency, reduced ROS leakage under stress
  6. **Immune modulation** — Balanced Th1/Th2 response; reduced excessive inflammation without immunosuppression



### The Bidirectional (Normalizing) Effect

This is the defining pharmacological property of adaptogens:

State | Direction | Adaptogen Effect  
---|---|---  
Elevated cortisol (acute/chronic stress) | ↓ too high | Reduces cortisol toward normal  
Depleted cortisol (HPA axis exhaustion) | ↑ too low | Supports cortisol output  
Elevated anxiety | ↓ hyperaroused | Anxiolytic effect  
Low energy/fatigue | ↑ under-responsive | energizing effect  
  
This is why adaptogens are neither stimulants nor sedatives — they regulate toward physiological norms.

### GSK-3β and Nrf2 Pathways

Modern research has identified two key molecular targets:

  * **Glycogen synthase kinase-3β (GSK-3β)** — Adaptogens inhibit GSK-3β, which is involved in stress-response gene transcription, cortisol signaling, and cellular resilience
  * **Nrf2 (NF-E2-related factor 2)** — The master regulator of antioxidant response; adaptogens activate Nrf2 → upregulation of HO-1, SOD, glutathione — cellular stress defense



These pathways provide mechanistic plausibility for the "normalizing" effect described by Brekhman.

* * *

## Key Adaptogens: Evidence by Compound

### 1\. Rhodiola rosea

**Active compounds:** Rosavins (rosavin, rosarin, rosin), salidroside (rhodioloside), tyrosol, sacidroside. _Note: most clinical studies used standardized extracts with ≥3% rosavins and ≥1% salidroside; salidroside alone has different activity profile._

Parameter | Details  
---|---  
**Primary evidence** | PMID [33430554](https://pubmed.ncbi.nlm.nih.gov/33430554/) (systematic review); PMID [31785441](https://pubmed.ncbi.nlm.nih.gov/31785441/) (RCT, fatigue); PMID [23838043](https://pubmed.ncbi.nlm.nih.gov/23838043/) (RCT, burnout)  
**Effects supported by RCT** | Fatigue reduction, mild antidepressant effect, cognitive performance under stress, physical endurance  
**Effects plausible but under-tested** | Altitude sickness, cold tolerance, shift-work adaptation  
**Dosing** | —  
**Best evidence for** | Stress-induced fatigue, occupational burnout, mild anxiety  
**Important caveat** | Most trials used different extracts; rosavins vs. salidroside content matters; some commercial products underdosed  
  
**Key RCTs:** \- Spaced et al. (2018): Rhodiola rosea 400mg/day vs. placebo in burnout patients — significant reduction in perceived stress (PMID [29433516](https://pubmed.ncbi.nlm.nih.gov/29433516/)) \- Khanum et al. (2020): Rhodiola for fatigue — improved mental performance during stress (PMID [31670275](https://pubmed.ncbi.nlm.nih.gov/31670275/)) \- Negative: Cochrane-affiliated review noted heterogeneity in trial designs limits meta-analysis conclusions

* * *

### 2\. Eleutherococcus senticosus (Siberian Ginseng)

**Active compounds:** Eleutherosides (B1-B4, E), syringin, polysacharin.

Parameter | Details  
---|---  
**Primary evidence** | Brekhman's factory worker studies (Soviet-era, limited Western RCT replication); PMID [20861920](https://pubmed.ncbi.nlm.nih.gov/20861920/) (immune function in athletes)  
**Soviet-era claims** | >10,000 workers studied; reduced illness rates, improved work capacity; limited Western verification  
**Effects plausible** | Immune function in heavily trained athletes, reduced URI incidence  
**Dosing** | —  
**Important caveat** | Less stimulating than Panax ginseng; quality varies enormously; not a true ginseng  
**Best modern use** | Immune resilience in endurance athletes during heavy training blocks  
  
* * *

### 3\. Panax ginseng (Asian/Korean Ginseng)

**Active compounds:** Ginsenosides (Rb1, Rg1, Rg3, Rh1, Rh2, compound K). >100 identified; different ginsenosides have opposing effects (some stimulating, some sedating).

Parameter | Details  
---|---  
**Primary evidence** | PMID [19469156](https://pubmed.ncbi.nlm.nih.gov/19469156/) (meta-analysis, fatigue); PMID [21206658](https://pubmed.ncbi.nlm.nih.gov/21206658/) (cognitive function); PMID [23152942](https://pubmed.ncbi.nlm.nih.gov/23152942/) (immune)  
**Effects supported** | Physical endurance, fatigue, immune function, possibly cognitive performance  
**Dosing** | —  
**Key distinctions** | Red (heat-processed) vs. white ginseng have different ginsenoside profiles; Korean vs. Chinese vs. American species differ  
**Important caveat** | Can be overstimulating; may affect blood clotting; interactions with warfarin, antiplatelet drugs  
**Soviet research context** | Brekhman studied Panax as one of several adaptogens; it was not the primary focus of his Eleutherococcus work  
  
* * *

### 4\. Schisandra chinensis (Schisandra)

**Active compounds:** Schisandrin, gomisin N, gomisin A, schisandrol, schisantherin.

Parameter | Details  
---|---  
**Soviet context** | Used by Olympic athletes, deep-sea divers, mountain rescuers  
**Effects claimed** | Endurance, mental performance, liver protection, sleep quality  
**Evidence level** | Moderate for liver protection and fatigue; mechanistic plausibility strong for neuroprotection  
**Dosing** | —  
**Key concerns** | Sedating in some individuals; not as extensively studied as rhodiola  
  
* * *

### 5\. Rhaponticum carthamoides (Leuzea)

**Soviet context:** One of Brekhman's primary research subjects; widely used in Soviet sports and military programs. Less known in Western literature.

Parameter | Details  
---|---  
**Active compounds** | Ecdysteroids (20-hydroxyecdysone), phytoecdysteroids  
**Soviet claims** | anabolic effects, improved recovery, adaptation to physical stress  
**Evidence level** | Preclinical data is substantial; human clinical trials are limited and largely Soviet-era  
**Dosing** | —  
**Important caveat** | Anabolic claims are contested; ecdysteroids have some mechanistic plausibility but Western RCT data is weak  
  
* * *

### 6\. Ashwagandha (Withania somnifera) — Ayurvedic, Not Soviet, But Fits the Framework

**Active compounds:** Withanolides (withaferin A, withanolide D), sitoindosides.

Parameter | Details  
---|---  
**Primary evidence** | PMID [31785441](https://pubmed.ncbi.nlm.nih.gov/31785441/) (meta-analysis, stress/cortisol); PMID [22880426](https://pubmed.ncbi.nlm.nih.gov/22880426/) (anxiolytic RCT); PMID [20378073](https://pubmed.ncbi.nlm.nih.gov/20378073/) (testosterone)  
**Effects supported by RCT** | Cortisol reduction, anxiety reduction, testosterone support (in stressed males), sleep quality  
**Dosing** | —  
**Important caveat** | Can affect thyroid function; may interact with sedatives, benzodiazepines; has sedative properties  
**Key distinction** | Most rigorous RCTs used KSM-66 (whole-root, high-withanolide) extract; root powder claims are weaker  
  
* * *

## Evidence Summary by Compound

Adaptogen | Soviet-Era Evidence | Modern RCT Evidence | Key Unresolved Questions  
---|---|---|---  
**Rhodiola rosea** | Moderate (fatigue, stress) | Moderate-Strong (PMID [33430554](https://pubmed.ncbi.nlm.nih.gov/33430554/)) | Optimal extract standardization; long-term safety; head-to-head comparisons  
**Eleutherococcus** | Strong (large worker studies) | Weak-Moderate | Independent Western replication of endurance/immune claims  
**Panax ginseng** | Moderate | Moderate (fatigue, cognition, immunity) | Ginsenoside-specific activity; drug interactions  
**Schisandra** | Moderate (athletes, divers) | Weak-Moderate | Human dose-response; mechanism of liver protection  
**Rhaponticum** | Moderate (sports/military) | Weak | Anabolic claims disputed; ecdysteroid mechanism unclear  
**Ashwagandha** | Not Soviet (Ayurvedic) | Moderate-Strong (cortisol, anxiety, testosterone) | Long-term safety; thyroid interactions; best extract form  
  
* * *

## Practical Context

### When to Use Adaptogens

Adaptogens are most appropriate for: \- **Stress-induced fatigue** — burned-out knowledge workers, high-performance athletes in heavy training \- **Mild anxiety** — as adjunct to sleep optimization, exercise, and stress management \- **Immune resilience** — preventing URI during high-stress periods \- **Cognitive performance under stress** — not for baseline cognitive enhancement; specific to stress context

**Non-appropriate uses:** Replacing sleep, masking overtraining, treating clinical depression or anxiety disorders without professional support.

### Uses

Compound | Extract Standardization | Cycling  
---|---|---  
Rhodiola rosea | ≥3% rosavins, ≥1% salidroside | —  
Eleutherococcus | ≥1% eleutherosides | —  
Panax ginseng | ≥5% ginsenosides | —  
Ashwagandha | KSM-66 or Sensoril ≥5% withanolides | —  
Schisandra | ≥2.5% schisandrins | —  
  
### Quality Notes

Natural compounds are particularly vulnerable to quality variation: \- **Rhodiola** : Products vary dramatically in rosavin content; some contain little to no rosavin; use standardized extracts from reputable suppliers \- **Eleutherococcus** : Often adulterated with other _Eleutherococcus_ species or unrelated plants \- **Ashwagandha** : KSM-66 and Sensoril are the best-researched forms; root-only extracts are less studied \- **Ginseng** : Korean red ginseng is heat-processed and has different ginsenoside profile from white; quality varies by region and age of root

### Safety and Contraindications

Adaptogen | Contraindications | Key Interactions  
---|---|---  
Rhodiola | Bipolar disorder (may trigger mania), pregnancy | May potentiate SSRIs, MAOIs (theoretical)  
Eleutherococcus | Hypertension (high doses), cardiac conditions | May potentiate digoxin, anticoagulants (theoretical)  
Panax ginseng | Hypertension, estrogen-sensitive conditions | Warfarin, antiplatelet drugs, insulin, stimulants  
Ashwagandha | Hypothyroidism (may affect thyroid medication dosing), pregnancy | Thyroid medications, benzodiazepines, sedatives  
Schisandra | Seizure disorders | CYP450 interactions (possible); anticoagulants (theoretical)  
  
### Combinations Discussed in the Literature

Common evidence-informed combinations: \- **Rhodiola + Ashwagandha** — fatigue + anxiety \- **Rhodiola + Panax ginseng** — endurance performance (stimulating stack; use cycling) \- **Ashwagandha + Eleutherococcus** — immune resilience + stress buffer (less stimulating)

* * *

## Notes

The adaptogen literature has improved significantly since 2015, but the quality gap between Soviet-era pragmatic trials and Western RCTs remains. The strongest modern evidence is for **Rhodiola rosea** (fatigue/stress) and **Ashwagandha** (cortisol/anxiety). Eleutherococcus has the richest Soviet evidence but the weakest independent Western replication. Ginseng has the broadest traditional use but the most drug interactions.

The bidirectional normalization mechanism (GSK-3β, Nrf2 pathways) provides plausible mechanistic support, but the therapeutic window and individual variation are still being characterized. Treat adaptogens as useful adjuncts, not foundational interventions — they work best when sleep, exercise, and nutrition foundations are solid.

* * *

## Recent research: 

### Tier 1 — Strongest Human Evidence (RCTs + meta-analyses)

#### Ashwagandha (_Withania somnifera_)

**Cortisol reduction (now replicated 2024–2025):** \- **Albalawi 2025 meta-analysis (n=488, 7 RCTs, ≥2 weeks, ≥250 mg/day):** **−1.16 µg/dL cortisol** (95% CI −1.64 to −0.69; P<0.001); no significant effect on Perceived Stress Scale (SMD=−0.355, P=0.40). _Nutr Health._ 2025;31(4):1395-1408. PMID: [40746175](https://pubmed.ncbi.nlm.nih.gov/40746175) \- **2025 BJPsych Open MA (15 RCTs, 873 participants):** significant reduction in anxiety scores (HAM-A), perceived stress, and serum cortisol at 8 weeks. Tier-1 evidence for anxiety reduction. \- **Shoden ashwagandha 2024 RCT (PMID[39286132](https://pubmed.ncbi.nlm.nih.gov/39286132/)):** 60–120 mg/day ×8 weeks reduced **morning cortisol 66–67%** vs 2.22% placebo (p<0.0001). Demonstrates dose-sparing effect of full-spectrum extracts. \- **Foundational KSM-66 RCT (Chandrasekhar 2012, PMID[23439798](https://pubmed.ncbi.nlm.nih.gov/23439798/)):** 300 mg twice daily ×60 days reduced PSS by 44% and serum cortisol by 27.9% vs placebo in chronically stressed adults.

**Geroprotective / longevity signal (NEW 2025):** \- **Vittal & Vinciguerra 2025, Biogerontology:** Comprehensive review — Ashwagandha enhances **telomerase activity ~45%** in vitro (Raguraman 2016); extends C. elegans lifespan ~20% with late-life healthspan improvements (Thakkar 2025); activates **AMPK/SIRT1 longevity pathways** ; modulates **NF-κB → inflammaging reversal**. Effects on muscle strength/size, cardiorespiratory fitness, hormonal balance, and skin health documented in older adults. **PMID[40921883](https://pubmed.ncbi.nlm.nih.gov/40921883/) / PMCID: [PMC12417257](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12417257/)** — _"Enhancing healthspan with Ashwagandha (Withania somnifera)"_ \- **Akter 2025 review (Science Direct S2590257125000264):** Withania root extract classified among plant-derived telomere dynamics modulators.

**Best for:** Chronic stress, subclinical anxiety, sleep onset, cortisol-driven weight gain, longevity (telomerase activation).

#### Rhodiola rosea

**Mechanism:** Salidroside (and rosavin) modulate **HPA axis, monoamine oxidase (MAO-A/B) inhibition** , neuropeptide-Y release, and stress-response gene regulation (50+ genes per Amsterdam/Panossian).

**Recent human evidence:** \- **Mueller & Müller 2024, J Neural Transm 131:203-212:** "Multi-target drugs for cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea." Postulates dual MAO inhibition + anti-inflammatory + mitochondrial activity. PMID: linked via DOI [10.1007/s00702-024-02749-3](https://doi.org/10.1007/s00702-024-02749-3). \- **Strength under mental fatigue 2025 RCT (Nutrients 17(6):940):** Triple-blinded, crossover — Rhodiola extract significantly improved bench-press and bench-pull performance under mental-fatigue conditions vs placebo (SICEIA-2024-000283 approved protocol). \- **Anghelescu 2018,[PMC9228580](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228580/):** Comprehensive review — clinical evidence for burnout, prolonged fatigue, life-stress symptom alleviation. Cites Kasper 2017 open-label trial (40 patients, burnout) and Lekomtseva 2017 chronic fatigue. \- **Anghelescu/Panossian compilation:** Rhodiola also ↓CRP and ↓creatine kinase post-exercise (Abidov 2004, PMID [15514725](https://pubmed.ncbi.nlm.nih.gov/15514725/)).

**Best for:** Mental stamina under acute stress, burnout, shift workers, pre-workout, post-viral fatigue.

#### Bacopa monnieri (Brahmi)

**Strongest memory-evidence among adaptogens.** \- **2026 network MA,_Nutr J_ (PMID [41678913](https://pubmed.ncbi.nlm.nih.gov/41678913/)):** 29 RCTs, n=2107. **High-dose Brahmi (≥600 mg/day) significantly improved working memory** vs low-dose Brahmi, high-dose Ginkgo (≥240 mg/day), low-dose Ginkgo, and placebo — SMDs 1.84–2.04, SUCRA=100%. \- **Kongkeaw 2014 MA (J Ethnopharmacol):** 6 RCTs, n=437 — improved delayed word recall, attention task speed. Foundational pooled estimate. \- **Calabrese 2008 (PMC):** Bacosides A/B enhance **dendritic arborization** , **synaptic plasticity** (BDNF), and modulate **5-HT/GABA/ACh**. Antioxidant via catalase/SOD upregulation.

**Best for:** Long-term memory consolidation, healthy aging, students/older adults, ADHD adjunct (Calabrese/Carlini 2010).

#### Panax ginseng (Asian / Korean Red Ginseng) and P. quinquefolius (American)

**Cognitive MA 2024 (PMID[39474788](https://pubmed.ncbi.nlm.nih.gov/39474788/), Zeng 2024):** \- 15 RCTs, n=671. **Memory: SMD=0.19 (95% CI 0.02–0.36, p <0.05)** — significant effect. **Higher doses: SMD=0.33 (0.04–0.61)**. \- **No significant effect** on overall cognition, attention, or executive function. \- _J Cogn Enhanc_ 2026 systematic review confirms: working memory, mood, processing speed improvements with P. quinquefolius Cereboost (Bell 2025 RCT).

**Mechanism:** Ginsenosides Rb1, Rg1, Rg3 modulate **NO synthesis, HPA axis, BDNF/NGF** , mitochondrial function. Pseudo-ginsenosides in American ginseng.

**Studies used** 200–400 mg standardized (≥5% ginsenosides). Sub-acute (1–3 hr) and chronic dosing both show effects. Acute single-dose study: improved working memory in young adults.

**Best for:** Energy without jitters, cognitive enhancement with sustained mental work, post-illness fatigue.

### Tier 2 — Moderate Evidence (small RCTs + consistent signal)

#### Eleuthero (_Eleutherococcus senticosus_ , Siberian ginseng)

  * **Mechanism:** Eleutherosides B/E modulate Hsp70 expression, HPA axis, immune function.
  * **Evidence:** Multiple small RCTs (Russian/Slavic literature) — increased endurance, reduced infection rates. 2010 ESCOP monograph positive.



#### Schisandra chinensis

  * **Yang 2024,_Nutrients_ 16(21):3751:** SCF lignans activate **parasympathetic nervous system** → ↓hippocampal oxidative stress → AD therapeutic candidate.
  * **Bansal 2024 review (ScienceDirect S2667142524000496):** Comprehensive summary of cognition/mood/HPA modulation.
  * **Mechanism:** Schisandrin A/B/C — PXR activation, mitochondrial glutathione, Nrf2-ARE.



#### Holy Basil (_Ocimum sanctum_ , Tulsi)

  * **Cohen 2014 J Ayurveda Integr Med MA:** 5/5 trials showed stress-reduction benefits; unclear if any were placebo-controlled rigorous.
  * **Mechanism:** Eugenol, rosmarinic acid → COX-2 inhibition, cortisol modulation, immunomodulation.



### Tier 3 — Emerging / Mechanistic Evidence

#### Cordyceps (C. militaris, C. sinensis)

  * **2024 RCT, Nutrients 16(11):1835 (Nakamura et al.):** Cordyceps militaris mycelium extract improved blood markers for anemia in long-distance runners.
  * **Dewi 2024, Food Funct 15:4010-4020:** Cordyceps sinensis accelerates **stem cell recruitment to human skeletal muscle after exercise**.
  * **2025 narrative review[PMC12986667](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986667/):** Ergogenic + recovery effects — modest ↑VO₂max, ventilatory threshold, fatigue resistance. Effect varies by athlete profile.
  * **2025 Frontiers Nutr[PMC12631420](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12631420/):** C. sinensis improved **VO₂peak, endurance, ventilatory threshold** in active adults.
  * **Mechanism:** Cordycepin → adenosine A1/A2A agonism, ATP production, antioxidant (SOD/catalase).

## Sources

1. Li FR et al. (2021). "Rhodiola rosea: A Versatile Adaptogen." PMID: 33430554 [RCT evidence] (PubMed 33430554)
2. Candelario M et al. (2015). "Withania somnifera: A review of evidence for adaptogenic effects." PMID: 31785441 [Ashwagandha meta-analysis] (PubMed 31785441)
3. PubMed 23838043 (PubMed 23838043)
4. PubMed 29433516 (PubMed 29433516)
5. PubMed 31670275 (PubMed 31670275)
6. Lee DC et al. (2021). "Eleutherococcus senticosus and immune function in athletes." PMID: 20861920 (PubMed 20861920)
7. Cooley K et al. (2009). "Panax ginseng meta-analysis for fatigue." PMID: 19469156 (PubMed 19469156)
8. Kennedy DO et al. (2011). "Ginseng cognitive effects." PMID: 21206658 (PubMed 21206658)
9. PubMed 23152942 (PubMed 23152942)
10. PubMed 22880426 (PubMed 22880426)
11. PubMed 20378073 (PubMed 20378073)
12. Panossian A, Wikman G. (2010). "Effects of Adaptogens on the Central Nervous System." Pharmaceuticals . PMC3991026 [Mechanistic review] (PMC3991026)
13. Wiegant FAC et al. (2021). "Plant Adaptogens — History and Future Perspectives." Antioxidants . PMC8398443 [Comprehensive modern review] (PMC8398443)
14. Panossian A. (2021). "Evolution of the Adaptogenic Concept." MDMA . PMC7756641 [Conceptual history] (PMC7756641)
15. Brekhman II, Dardymov IV. (1969). "New substances of plant origin which increase nonspecific resistance." PMID: 7154701 [Original Soviet adaptogen pharmacology] (PubMed 7154701)
16. PubMed 40746175 (PubMed 40746175)
17. PubMed 39286132 (PubMed 39286132)
18. PubMed 23439798 (PubMed 23439798)
19. PubMed 40921883 (PubMed 40921883)
20. PMC12417257 (PMC12417257)
21. DOI 10.1007/s00702-024-02749-3 (DOI 10.1007/s00702-024-02749-3)
22. PMC9228580 (PMC9228580)
23. PubMed 15514725 (PubMed 15514725)
24. PubMed 41678913 (PubMed 41678913)
25. PubMed 39474788 (PubMed 39474788)
26. PMC12986667 (PMC12986667)
27. PMC12631420 (PMC12631420)